Friday, 25 July 2014
Last updated 14 min ago
Dec 4 2013 | 2:17pm ET
When Pershing Square Capital Management has been in the news this year, the news has been almost uniformly bad. The hedge fund's $1 billion short against Herbalife Inc. has suffered a $500 million paper loss and dragged firm founder William Ackman into a nasty public feud with Carl Icahn. And Pershing Square's huge investment in J.C. Penney Co. also cost it a half-billion dollars this year.
But in spite of those sizeable setbacks, the $12 billion New York-based firm is poised to post very respectable returns, indeed, this year. Pershing Square's flagship hedge fund is up 10% this year after rising 1.4% last month, easily topping most industry indices.
Pershing Square's offshore International Fund is nearing double digits, up 9.4% after a 1.2% jump in November.
Most of the firm's turnaround is due to its 7.9% return in October.
Jul 8 2014 | 10:48am ET
The surge in derivatives regulation is among the most complex challenges facing the financial services industry today. Northern Trust’s Joshua Satten recently spoke with FINalternatives to share insights into the challenges presented by new regulation and explore how the industry is responding. Read more…